News

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.
Novartis Drug Cosentyx Fails Late-stage Trial for Artery Disease Novartis said on Thursday that its Cosentyx drug had failed in a late-stage trial on adults with giant cell arteritis (GCA), a ...